Scientists analyze old data to Fine-Tune prostate cancer care
NCT ID NCT04541030
Summary
This study is looking back at medical data from men who had surgery for prostate cancer. Researchers want to see if a special genomic test (GPS), when used with MRI scans, can better predict which men might have hidden, more aggressive cancer. The goal is to improve how doctors select patients for a less-invasive treatment that targets only the cancerous part of the prostate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Institute (NCI)
Bethesda, Maryland, 20892, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.